ALEC - Alector to Host Virtual Research and Development Event Highlighting Alector Brain Carrier Blood-Brain Barrier Technology Platform | Benzinga
SOUTH SAN FRANSISCO, Calif., June 10, 2024 (GLOBE NEWSWIRE) -- Alector, Inc. (NASDAQ:ALEC), a clinical-stage biotechnology company pioneering immuno-neurology, today announced management will host a virtual event to discuss Alector Brain Carrier, a proprietary, versatile blood-brain barrier (BBB) technology platform that is being applied selectively to the Company's next-generation product candidates and research pipeline. The event will include a presentation from Alector's management team as well as a leading scientific expert who will offer insights into emerging technologies for BBB modulation and discuss future directions and opportunities in the field.
Details of the webinar are as follows:
Crossing the Blood-Brain Barrier: Advancing ...